Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma. | Clin Interv Aging;8: 889-97, 2013. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma.

Gong, Dao-Jun; Zhang, Jia-Min; Yu, Min; Zhuang, Bo; Guo, Qing-Qu.

Affiliation

Gong DJ; Department of Hepatobiliary-Pancreatic Surgery, Jinhua Hospital of Zhejiang University, Jinhua, People's Republic of China.

Clin Interv Aging ; 8: 889-97, 2013.

Article in En | MEDLINE | ID: mdl-23898224

Subject(s)
Key words

combination therapy; inhibition of SIRT1-gemcitabine; pancreatic carcinoma

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Benzamides / Deoxycytidine / Sirtuin 1 / Naphthols Limits: Animals Language: En Journal: Clin Interv Aging Journal subject: GERIATRIA Year: 2013 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Benzamides / Deoxycytidine / Sirtuin 1 / Naphthols Limits: Animals Language: En Journal: Clin Interv Aging Journal subject: GERIATRIA Year: 2013 Document type: Article Country of publication: